Houston, TX, United States of America

Yunfei Wen

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunfei Wen. Retrieved from https://idiyas.com/inventor/yunfei-wen-nextwego

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yunfei Wen in Therapeutic Peptides

Introduction

Yunfei Wen is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of therapeutic peptides, particularly in their application for cancer treatment. His innovative work has the potential to impact the medical community and improve patient outcomes.

Latest Patents

Yunfei Wen holds a patent for therapeutic peptides that can alter EphB4/EFNB2 signaling. This invention is particularly noteworthy as it can be utilized in the treatment of cancer. The peptides are designed to be incorporated into nanoparticles, such as core-cross-linked polymeric micelles (CCPM), enhancing their effectiveness in therapeutic applications.

Career Highlights

Yunfei Wen is affiliated with the University of Texas System, where he continues to advance his research and development in the field of therapeutic peptides. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.

Collaborations

Yunfei Wen collaborates with Chiyi Xiong, who is also involved in research related to therapeutic peptides. Their partnership exemplifies the collaborative spirit of scientific inquiry and innovation.

Conclusion

Yunfei Wen's contributions to the field of therapeutic peptides represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…